ID1 and neoplasm: In the 4T1 xenograft tumor model experiment, compared with the WT group, the KD-ID1 group exhibited a significant reduction in tumor volume, and simultaneously, the number of positive cells for the angiogenesis marker CD31 was significantly decreased (Figures 9D–G, p < 0.01).